Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Conditions
/ Adult Fibrosarcoma
Adult Fibrosarcoma
8 registered clinical trials studyying Adult Fibrosarcoma.
Status
Trial
Sponsor
Phase
Completed
Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma
NCT01532687
OHSU Knight Cancer Institute
Phase 2
Completed
Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced
NCT01154452
National Cancer Institute (NCI)
Phase 1 / Phase 2
Completed
Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metasta
NCT00720174
National Cancer Institute (NCI)
Phase 1
Completed
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
National Cancer Institute (NCI)
Phase 2
Completed
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft
NCT00346164
Children's Oncology Group
Phase 3
Completed
Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma
NCT00112463
National Cancer Institute (NCI)
Phase 2
Completed
Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans
NCT00084630
National Cancer Institute (NCI)
Phase 2
Terminated
S9624 Ifosfamide in Treating Patients With Meningeal Tumors
NCT00003292
SWOG Cancer Research Network
Phase 2